Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China

References

• Plotkin SA, Orenstein WA, Offit PA , et al. Vaccines. 7th ed. Holland: Elsevier; 2017. p. 970–8. ISBN: 9780323357616.
   Google Scholar
• Plotkin SA. Rubella eradication: not yet accomplished, but entirely feasible. J Infect Dis. 2021;224(12 Suppl 2):S360–S366. doi:10.1093/infdis/jiaa530.
   PubMedGoogle Scholar
• World Health Organization. Measles and rubella strategic framework 2021–2030. Geneva: World Health Organization; 2020. https://measlesrubellainitiative.org/measles-rubella-strategic-framework-2021-2030/ .
   Google Scholar
• Kirby T. Rubella is eliminated from the Americas. Lancet Infect Dis. 2015;15(7):768–69. doi:10.1016/S1473-3099(15)00102-4.
   PubMed Web of Science ®Google Scholar
• Su Q, Ma C, Wen N, Fan C, Yang H, Wang H, Yin Z, Feng Z, Hao L, Yang W. Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine. Vaccine. 2018;36(16):2079–85. doi:10.1016/j.vaccine.2018.03.013.
   PubMed Web of Science ®Google Scholar
• He H, Xie S, Li Q, et al. Serologic and epidemiological effect of rubella-containing vaccine immunization activities among third-year students of middle school in some areas of Zhejiang Province. Chin J Vaccines Immunization. 2016;22(1):20–23.
   Google Scholar
• Wang Y, Xu W, Wang H, et al. Rubella antibody levels among children before and after implementing the Expanded National Immunization Program in five counties of China. Chin J Vaccines Immunization. 2017;23(2):162–6+161.
   Google Scholar
• Charlton CL, Lai FY, Dover DC. How to determine protective immunity in the post-vaccine era. Hum Vaccin Immunother. 2016;12(4):903–06. doi:10.1080/21645515.2015.1128600.
   PubMed Web of Science ®Google Scholar
• Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol. 1996;106(2):170–74. doi:10.1093/ajcp/106.2.170.
   PubMed Web of Science ®Google Scholar
• Ni L, Xu J, Zhang C. Epidemiological characteristic and trend of rubella in Guangzhou, 2005-2019. Morden Prev Med. 2021;48(11): 1938–40+2074.
   Google Scholar
• Ma J, Luo H, Hao L, et al. Analysis on epidemiological characteristics of rubella in China during 2005-2011. Chin J Vaccines Immunization. 2012;18(6):500–3+540.
   Google Scholar
• Bogusz J, Paradowska-Stankiewicz I. Rubella in Poland in 2017. Przegl Epidemiol. 2019;73(3):305–10. doi:10.32394/pe.73.35.
   PubMedGoogle Scholar
• Zhiying Y, Jianyue Z, Xiaoying G. Epidemiology of rubella in Quzhou，Zhejiang, 2004 to 2012. Dis Surveillance. 2013;28:672–75.
   Google Scholar
• Su Q, Feng Z, Hao L, Ma C, Hagan JE, Grant GB, Wen N, Fan C, Yang H, Rodewald LE, et al. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study. Lancet Infect Dis. 2021;21(7):1004–13. doi:10.1016/S1473-3099(20)30475-8.
   PubMed Web of Science ®Google Scholar
• Liu J. Epidemiological characteristics and coping strategies of rubella in Xi’An City from 2004-2011. Occup Health. 2012;28(17):2128–9+2132. doi:10.13329/j.cnki.zyyjk.2012.17.036.
   Google Scholar
• Zhu L, Zhang Z, Dong G. Epidemiological analysis of measles in Shenyang City from 2010 to 2019. J Community Med. 2021;19(3):146–49. doi:10.19790/j.cnki.JCM.2021.03.04.
   Google Scholar
• Takeshita K, Takeuchi N, Ohkusu M, Ohata M, Suehiro M, Maejima H, Abe H, Ohta F, Ohama Y, Tamai K, et al. Population-Based study of a free rubella-specific antibody testing and immunization campaign in Chiba city in response to the 2018–2019 nationwide rubella outbreak in Japan. Hum Vaccin Immunother. 2021;17(6):1779–84. doi:10.1080/21645515.2020.1847584.
   PubMed Web of Science ®Google Scholar
• Oishi K, Satoh H, Tanaka-Taya K. Re-emerging rubella epidemic and public health measures in Japan. Yakugaku Zasshi. 2020;140(7):901–04. doi:10.1248/yakushi.19-00255-3.
   PubMed Web of Science ®Google Scholar
• Piffer S, Pedron M, Dal Martello M, Caciagli P, Lanzafame P, Saugo M, Ferro A. Rubella immunity status and the active offer of MMR/MMRV vaccination during pregnancy. Ann Ist Super Sanita. 2021;57(1):26–32. doi:10.4415/ANN_21_01_04.
   PubMed Web of Science ®Google Scholar
• Knapp JK, Mariano KM, Pastore R, Grabovac V, Takashima Y, Alexander JP, Reef SE, Hagan JE. Progress toward rubella elimination — Western Pacific Region, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69(24):744–50. doi:10.15585/mmwr.mm6924a4.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhu Z, Xu Q, Fang X, Liu X, Xiong P, Song L, Xu W, Xu A. Progress towards rubella elimination after implementation of rubella immunization for over 20 years in Shandong province, China. Sci Rep. 2017;7(1):17982. doi:10.1038/s41598-017-18281-2.
   PubMedGoogle Scholar
• Kaaijk P, Nicolaie MA, van Rooijen D, van Houten MA, van der Klis FR, Buisman A-M, van Binnendijk RS. Dynamics of the antibody response after a third dose of measles-mumps-rubella vaccine indicate a slower decline compared with a second dose. Open Forum Infect Dis. 2020;7(11):ofaa505. doi:10.1093/ofid/ofaa505.
   PubMed Web of Science ®Google Scholar
• Chan J, Wu Y, Wood J, Muhit M, Mahmood MK, Karim T, Moushumi F, Jones CA, Snelling T, Khandaker G, et al. Burden of Congenital Rubella Syndrome (CRS) in Bangladesh: systematic review of existing literature and transmission modelling of seroprevalence studies. Infect Disord Drug Targets. 2020;20(3):284–90. doi:10.2174/1871526518666181004092758.
   PubMedGoogle Scholar
• Shanmugasundaram D, Awasthi S, Dwibedi B, Geetha S, Jain M, Malik S, Patel B, Singh H, Tripathi S, Viswanathan R, et al. Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20. PLoS Negl Trop Dis. 2021;15(7):e0009608. doi:10.1371/journal.pntd.0009608.
   PubMed Web of Science ®Google Scholar
• Motaze NV, Mthombothi ZE, Adetokunboh O, et al. The impact of rubella vaccine introduction on rubella infection and congenital rubella syndrome: a systematic review of mathematical modelling studies. Vaccines. 2021;9(2):84. doi:10.3390/vaccines9020084.
   Web of Science ®Google Scholar
• Ma C, Su Q, Wen N, et al. Evaluation of the measles surveillance system performance in China, 2015-2016. Chin J Vaccines Immunization. 2018;24(2):141–45.
   Google Scholar